Rheumatoid Arthritis and Intermittent Fasting

Rheumatoid arthritis intermittent fasting is a growing area of interest for people looking to complement their prescribed treatment with lifestyle changes. Rheumatoid arthritis (RA) is a chronic autoimmune condition causing joint inflammation, pain and stiffness, managed primarily with DMARDs and biologics under NHS and NICE guidance. Some individuals report symptom improvements during fasting periods, and early research suggests fasting may influence inflammatory pathways. However, the evidence remains limited, and fasting should always be considered alongside, not instead of, prescribed medical treatment. This article explores what the current evidence shows and how to approach fasting safely with RA.

Can intermittent fasting help with rheumatoid arthritis symptoms?

Some people with RA report improvements in joint pain and stiffness during intermittent fasting, but no UK clinical guideline recommends it as a treatment, and it should complement rather than replace prescribed DMARDs or biologics.

Some people with rheumatoid arthritis (RA) report improvements in joint pain, stiffness and fatigue when they adopt intermittent fasting, though the evidence base remains early and no UK clinical guideline currently includes fasting as a recommended treatment for RA. Rheumatoid arthritis is a chronic autoimmune condition in which the immune system attacks the synovial lining of joints, causing inflammation, pain and, over time, structural damage. Managing it typically involves disease-modifying antirheumatic drugs (DMARDs), biologics and lifestyle measures recommended by a rheumatology team.

Intermittent fasting refers to structured patterns of eating and voluntary fasting, rather than restricting specific foods. Common approaches include time-restricted eating (for example, eating within an eight-hour window each day) and alternate-day or periodic fasting. Interest in fasting as a complementary strategy for inflammatory conditions has grown, partly because caloric restriction and fasting periods appear to influence several biological pathways relevant to inflammation.

NICE guideline NG100 (Rheumatoid arthritis in adults: management) sets out a treat-to-target approach using DMARDs and biologics as the foundation of RA care, and does not include dietary interventions such as fasting among its core recommendations.^[1][2] NHS patient guidance on living with RA acknowledges that maintaining a healthy weight and following a balanced diet can support overall wellbeing in people with inflammatory arthritis. EULAR recommendations on lifestyle behaviours in rheumatic and musculoskeletal diseases similarly highlight the relevance of diet and weight management as adjuncts to medical treatment.^[3][4] Intermittent fasting may be one way some individuals achieve those broader goals, provided it is approached safely and with appropriate clinical support.

For people living with RA, any dietary change should be considered alongside, not instead of, prescribed medical treatment.

What does the evidence say about fasting and joint inflammation?

Fasting may reduce inflammatory markers such as CRP and IL-6, but evidence in RA is low quality, short-term and insufficient to establish a clear clinical benefit or disease-modifying effect.

The available evidence suggests that fasting may reduce several markers of systemic inflammation, including C-reactive protein (CRP) and interleukin-6 (IL-6), both of which are commonly elevated in active RA. However, most studies are small, short-term and not conducted exclusively in RA populations, and findings are mixed. A frequently cited observation is that some patients with RA report symptom relief during Ramadan fasting, with a return of symptoms after the fasting period ends; observational studies and systematic reviews on this topic suggest any benefit may be transient rather than disease-modifying, though the evidence is limited and heterogeneous.^[7][8]

Laboratory and preclinical research indicates that fasting periods can shift immune cell activity, reduce oxidative stress and promote autophagy, a cellular process that clears damaged proteins and organelles.^[9][26] These mechanisms represent biologically plausible routes by which fasting might dampen inflammatory signalling, but translating preclinical findings into reliable clinical recommendations for RA requires larger, well-designed randomised controlled trials, which are currently lacking.

A 2019 systematic review published in the journal Nutrients examined dietary interventions in RA and found that caloric restriction and fasting were associated with short-term reductions in disease activity scores in some participants, but the quality of evidence was rated as low to moderate.^[10] The authors noted significant heterogeneity between studies in terms of fasting protocols, outcome measures and patient populations. More recent systematic reviews and evidence summaries have not substantially changed this picture: the overall certainty of evidence remains low, and no Cochrane review has yet established a clear clinical benefit for fasting specifically in RA.

Based on current evidence, fasting does not appear to alter the underlying autoimmune process in RA in the way that DMARDs or biologics do. Any anti-inflammatory benefit is likely to be modest and adjunctive. People with RA should not interpret early positive findings as a reason to reduce or stop prescribed medication without discussing this with their rheumatologist.

How might different fasting patterns affect RA differently?

Time-restricted eating is generally the most sustainable pattern for RA, while alternate-day fasting carries the highest risk of nutritional inadequacy, particularly for those on corticosteroids or methotrexate.

Different intermittent fasting protocols may have varying effects on RA symptoms, and the most suitable approach will depend on an individual's disease activity, medication regimen, nutritional status and overall health. The main patterns discussed in the context of inflammatory arthritis include:

• Time-restricted eating (TRE): Limiting food intake to a defined window, commonly 8 to 10 hours per day. This approach is generally considered more sustainable for daily life than more demanding protocols, though comparative adherence data in RA populations are limited. Some people with RA find it easier to manage morning stiffness if they align their eating window with the time of day when symptoms are less severe.

• 5:2 fasting: Eating normally for five days and significantly restricting calories (typically to around 500 to 600 kcal) on two non-consecutive days. This pattern may be harder to maintain for people whose RA symptoms fluctuate unpredictably, as low-calorie days can coincide with flares.

• Alternate-day fasting: Alternating between normal eating days and fasting or very low-calorie days. This is the most demanding pattern and carries a higher risk of nutritional inadequacy, particularly relevant for people with RA who may already have increased nutritional needs due to systemic inflammation or corticosteroid use.

Corticosteroids, which are sometimes prescribed during RA flares, can cause blood glucose fluctuations and increase appetite, making prolonged fasting periods more challenging and potentially less safe. Methotrexate, a commonly used DMARD, is co-prescribed with folic acid and requires adequate hydration; significant dietary restriction may make it harder to maintain consistent food intake and fluid levels, which can affect tolerability and adherence to the medication regimen. The BNF and methotrexate SmPC both highlight the importance of folic acid supplementation and adequate hydration during methotrexate therapy. Similarly, leflunomide requires careful monitoring and has specific contraception requirements; any dietary change should be discussed with the prescribing team.^[22][23] Some RA medicines, including NSAIDs and sulfasalazine, are best taken with food to reduce gastrointestinal side effects, and an eating window should be planned to accommodate this.^[14][15]

The pattern chosen should always be discussed with a healthcare professional familiar with the individual's full medication list and nutritional needs.

Practical tips for trying intermittent fasting with rheumatoid arthritis

Start with a 10 to 12-hour eating window, prioritise anti-inflammatory foods, stay well hydrated, time medications carefully with food, and avoid fasting during active flares.

People with RA who wish to explore intermittent fasting should approach it gradually and with a clear plan to protect both joint health and nutritional status. The following practical considerations may help:

• Start with a modest eating window: Beginning with a 10 to 12-hour eating window and narrowing it gradually, rather than jumping straight to a strict 8-hour window, allows the body to adapt and makes it easier to identify any impact on symptoms or energy levels.

• Prioritise anti-inflammatory foods during eating periods: Focus on oily fish (rich in omega-3 fatty acids), colourful vegetables, legumes, wholegrains, nuts and olive oil. These foods align with a Mediterranean-style dietary pattern, which systematic reviews and randomised controlled trials (including those published in journals such as RMD Open and Nutrients) suggest may be associated with reductions in inflammatory markers and disease activity in RA, though the overall quality of evidence remains moderate and individual responses vary.

• Stay well hydrated: Drinking adequate water throughout the day, including during fasting periods, supports general wellbeing and helps reduce the risk of side effects from some RA medications, including methotrexate, which requires good hydration for safe use.

• Time medications carefully: Some RA medications must be taken with food to reduce gastrointestinal side effects.^[14][15] Adjusting an eating window should never mean skipping doses or taking medication on an empty stomach if the prescribing information advises otherwise. Always check with a pharmacist or GP before changing the timing of any medication.

• Monitor for flares: Keep a simple symptom diary noting joint pain, stiffness, fatigue and any changes in disease activity. This information is valuable for both personal decision-making and for sharing with a rheumatology team.

• Avoid fasting during active flares: Periods of high disease activity increase the body's energy and nutritional demands. Restricting food intake during a flare may worsen fatigue and impair recovery. NHS and BSR patient guidance on managing RA flares emphasises the importance of maintaining nutrition and seeking prompt medical advice if symptoms worsen significantly.

Maintaining adequate protein intake is particularly important for people with RA, as systemic inflammation can contribute to muscle loss over time. People who are underweight, frail, older adults, adolescents, or those with diabetes at risk of hypoglycaemia should seek individualised advice before attempting any fasting regimen, as these groups face additional risks that require specialist input.

When should you talk to your rheumatology team before changing your diet?

Speak to your rheumatology team or GP before fasting if you take corticosteroids, methotrexate or leflunomide, have comorbidities such as diabetes or osteoporosis, or are pregnant or underweight.

Anyone with rheumatoid arthritis should speak to their rheumatology team or GP before making significant changes to their diet, particularly if those changes involve prolonged fasting periods or substantial caloric restriction. This conversation is especially important in certain circumstances:

• If you are taking corticosteroids: Steroids affect blood glucose regulation and appetite, and fasting can interact unpredictably with these effects.

• If you are on methotrexate or leflunomide: These DMARDs require consistent nutritional support and adequate hydration. The BNF and respective SmPCs highlight the importance of folic acid co-prescription with methotrexate and specific monitoring requirements for leflunomide. Significant dietary restriction may affect tolerability and adherence to these medicines.

• If you have comorbidities: Conditions such as type 2 diabetes (particularly where there is a risk of hypoglycaemia), osteoporosis (which is more common in people with RA), cardiovascular disease or kidney disease may make certain fasting patterns unsuitable or require additional monitoring.^[19][20]

• If you are underweight, frail or have a history of disordered eating: Fasting is not appropriate in these circumstances and could cause harm.

• If you are pregnant or planning pregnancy: Caloric restriction during pregnancy is not recommended. Methotrexate and leflunomide are both teratogenic and require effective contraception and, in the case of leflunomide, a washout procedure before conception; these requirements are detailed in the BNF and respective SmPCs and should always be discussed with a specialist.^[11][13]

If you experience a significant worsening of joint symptoms, new or severe fatigue, dizziness, or signs of a medication side effect during any dietary change, contact your GP in the first instance. For urgent concerns, NHS 111 can provide advice. If you suspect you are experiencing a side effect from a prescribed medicine, you can report this to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Do not stop prescribed RA medication without medical guidance, as this can lead to rapid disease flare and joint damage.

A registered dietitian with experience in inflammatory conditions can provide personalised guidance on how to structure an eating pattern that supports both RA management and overall nutritional health. Your rheumatology team may be able to refer you to one through the NHS.

Frequently Asked Questions